B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GGCX

MOLECULAR TARGET

gamma-glutamyl carboxylase

UniProt: P38435NCBI Gene: 26771 compounds

GGCX (gamma-glutamyl carboxylase) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GGCX

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Vitamin K 21.102

About GGCX as a Drug Target

GGCX (gamma-glutamyl carboxylase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented GGCX interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GGCX inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.